In Brief: FDA Division of OTC Drug Evaluation
This article was originally published in The Rose Sheet
Executive Summary
FDA Division of OTC Drug Evaluation: Debra Bowen, MD, has been officially named director of FDA's Division of OTC Drug Evaluation, Office of Drug Evaluation V Director Michael Weintraub, MD, announced at CTFA's "Meet the Regulators" conference Jan. 24 in Washington, DC. Bowen was appointed acting director of the division in September following the reorganization of FDA's Center for Drug Evaluation and Research ("The Rose Sheet" Sept. 25, p. 9)...